RETATRUTIDE

Retatrutide is an investigational triple-hormone agonist targeting GIP, GLP-1, and glucagon receptors that helps with substantial weight loss and improvements in blood-sugar control, with additional improvements reported in measures related to sleep apnea, knee osteoarthritis, cancer treatment, etc.